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Abstract
Background: Epilepsy affects 70 million people worldwide, 80% of
whom are in low-and-middle income countries (LMICs). Infections of
the central nervous system (CNS) contribute considerably to the
burden of epilepsy in LMICs, but the nature and presentation of
epilepsy following these infections is not fully understood. We
examined if epilepsy foutcomes are associated with the exposure to
parasitic infections.
Methods: This was a case-comparison study nested in a crosssectional survey of people with active convulsive epilepsy, with cases
as those exposed to parasitic infections, and comparison as those
unexposed. Associations of exposure to parasites with clinical and
electroencephalographic features of epilepsy were done using a
modified mixed effects Poisson regression model across five sites in
Africa. Multiplicative and additive scale (RERI) interactions were
explored to determine the effect of co-infections on epilepsy features.

article can be found at the end of the article.
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Population attributable fractions (PAF) were calculated to determine
the proportion of severe clinical and electroencephalographic features
of epilepsy attributable to CNS infections.
Results: A total of 997 participants with active convulsive epilepsy
from the five African sites were analyzed, 51% of whom were males.
Exposure to parasitic infections was associated with more frequent
seizures in adult epilepsy (relative risk (RR)=2.58, 95% confidence
interval (95%CI):1.71-3.89). In children, exposure to any parasite was
associated with convulsive status epilepticus (RR=4.68, (95%CI: 3.795.78), intellectual disabilities (RR=2.13, 95%CI: 1.35-3.34) and
neurological deficits (RR=1.92, 95%CI: 1.42-2.61). Toxoplasma gondii
and Onchocerca volvulus interacted synergistically to increase the risk
of status epilepticus (RERI=0.91, 95%CI=0.48-1.35) in the data pooled
across the sites. Exposure to parasitic infections contributed to 30% of
severe features of epilepsy as shown by PAF.
Conclusions: Parasitic infections may determine features and
phenotypes of epilepsy through synergistic or antagonistic
interactions, which can be different in children and adults.
Interventions to control or manage infections may reduce
complications and improve prognosis in epilepsy.
Keywords
Epilepsy, parasitic infections, status epilepticus, neurologic deficits,
intellectual disabilities, seizures, Africa
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Introduction

Epilepsy is a common serious neurological disorder, with an
estimated 70 million people being affected, 90% of whom live
in low-and-middle-income countries (LMICs) (Ngugi et al.,
2010). Global incidence of epilepsy is up to 278 per 100,000
people, while global prevalence is up to 11 per 1,000 people
(Fiest et al., 2017), with both incidence and prevalence being
higher in LMICs than high-income countries (HICs) (Newton
& Garcia, 2012). The higher burden of epilepsy in LMICs
can be attributed to the higher incidence of infections such as
malaria and human immunodeficiency virus (HIV), birth-related
injuries and low accessibility to health care (Newton & Garcia,
2012).
A study carried out in selected African populations indicated
that exposure to multiple parasites was associated with the
risk of epilepsy (Kamuyu et al., 2014). However, this study
did not determine the contribution of infections to features and
phenotypes of epilepsy and examine response to anti-seizure
medications (ASM) (Kariuki et al., 2014). It is important to
describe the features and phenotypes of epilepsy ascribable to
exposure to infections since most infections are preventable
through simple public health interventions. Infections such as
malaria and HIV can increase the risk for status epilepticus
(Kariuki et al., 2015a) and frequent seizures, both of which
worsen prognosis of epilepsy. Early onset epilepsy, which
is common in Africa, may be caused by infections, which
affects children because of undeveloped immunity and brain.
Infections may also damage the brain resulting in comorbidities of severe epilepsy such as intellectual disability and
neurological deficits, which can affect adherence to ASM
(Ibinda et al., 2017; Mbuba et al., 2012). Additionally, exposure to infections may complicate biomedical treatment of
epilepsy. It important to determine the burden of severe
epilepsy that could be prevented by control of infections. Findings from such studies may be useful in informing policy
makers on the impact that control of these infections may
have on the burden of epilepsy, particularly towards efforts to
reduce the clinical and psychosocial burden of epilepsy.
We performed an analysis of people with epilepsy with
well-defined clinical features to examine if exposure to common
central nervous system (CNS) infections may play a role
in the early onset of epilepsy, convulsive status epilepticus,
frequent seizures, abnormal electroencephalograph (EEG) findings, intellectual disabilities, neurological deficits as well
as other medical comorbidities of epilepsy e.g. malnutrition.
We computed the proportion of severe epilepsy that is attributable to these infections, which allows us to estimate the clinical
and psychosocial burden of epilepsy that would be eliminated
following the control of these infections.

Methods
Ethical considerations

The study was approved by the ethics committees or ethics
review boards in each of the participating countries (Clearance
number: M080455 for Agincourt, South Africa; IHI/IRB/No A
70-2009 for Ifakara, Tanzania; Reference number: HS 663 for

Iganga, Uganda; SSC number 787 for Kilifi, Kenya; FWA number
00011103 for Kintampo, Ghana;). All participants or guardians
gave written informed consent before responding to study-related
questions.

Study site and population
The study was carried out in sites in five African countries with
Health Demographic Surveillance Systems (HDSS), which
are part of the International Network for the Demographic
Evaluation of Populations and Their Health (INDEPTH):
Agincourt, South Africa; Kintampo, Ghana; Kilifi, Kenya;
Ifakara, Tanzania; and Iganga-Mayuge, Uganda. These sites
collect health and vital demographic data from residents on
a regular cyclical basis. The study population for each HDSS
was described in detail previously (Ngugi et al., 2013).
Study design
People with epilepsy were identified from a 3-stage
community cross-sectional survey carried out between 2008
and 2011 (Ngugi et al., 2013). Screening for history of convulsions was conducted in stage I, followed by administration of
a detailed questionnaire to describe seizures in stage II, and
a neurological assessment by a clinician to diagnose epilepsy
in stage III. Formal validation of this three-stage methodology is published elsewhere (Ngugi et al., 2012), and findings
supported need for continued efforts to develop and improve
case-ascertainment methods in population-based epidemiological studies of epilepsy in LMIC. Community members
diagnosed with epilepsy were tested for antibodies to HIV and
infectious parasites (Toxacara canis, Onchocerca volvulus,
Plasmodium falciparum, Toxoplasma gondii, and Taenia
solium) and formed the sample for this case-comparison study.
The exposure was any of the listed infections and the outcomes
were the presenting features of epilepsy. All study materials
can be found as extended data (Langat et al., 2021).
Sampling
The population consisted of 1,711 patients diagnosed with
epilepsy in the five sites. Respondents were tested for Toxacara
canis, Onchocerca volvulus, Plasmodium falciparum, Toxoplasma
gondii, HIV and Taenia solium (exposed). HIV was tested
because it is often cormobid with these parasitic infections.
Sample size calculation showed this study needed 386
participants to determine the association between features of
epilepsy and infections at 80% power and 95% level of confidence (supplementary appendix 1). However, we utilized all
data available (997 patients) in this study.
Procedure
Clinical assessments and definitions. Most clinical and
EEG features, treatment and detrimental consequences were
obtained through clinical examination and EEG recordings
performed by trained clinicians, and questionnaires. The clinical
and neurophysiological features of epilepsy have been reported
previously (Kariuki et al., 2014; Kariuki et al., 2015b). Epilepsy was defined as ≥2 unprovoked seizures occurring at least
24 hours apart and was classified as active if at least one seizure
occurred within the previous 12 months (Thurman et al., 2011).
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Briefly, convulsive status epilepticus was defined as seizures
lasting >30 minutes or intermittent seizures lasting for 30
minutes without recovery of consciousness. Seizure frequency
was categorized into daily (at least one each day), weekly
(at least one a week), monthly (at least one a month), and
yearly (at least one a year). An EEG was categorized as
abnormal if there was evidence of an abnormal background,
focal changes, interictal epileptiform activity or an abnormal
response to either of the activation procedures (hyperventilation or photic stimulation). Seizures were classified as focal,
generalized, or other. Intellectual disability was assessed by
a clinician observing young children who had problems
performing the standardized test of a locally adapted developmental inventory, or by assessing an adult’s awareness of person,
place and time. Malnutrition was defined as a weight-for-age
z score value of −2 or lower or a mid-upper arm circumference less than 11.5 cm. Neurological deficits were defined as
an inability to do things and walk or sit upright if of an appropriate age. Severe epilepsy was considered in a person with
epilepsy plus focal seizures, frequent seizures, abnormal
EEG, neurological deficits or intellectual disability.
Serological assay analysis. Data on assays for parasitic and
HIV infections were obtained from the work by Kamuyu
and colleagues (Kamuyu et al., 2014). They determined
infection status through analysis of blood samples to detect
antibodies to the infectious parasites and HIV. The kits and
techniques used, criteria for cut-off and sensitivity and specificity have been described (Kamuyu et al., 2014). These
assays were performed on 986 people with epilepsy.

Data management and statistical analysis
The data was exported from MS Excel to STATA version
15 for sampling and analysis. Data cleaning was done to assess
completeness of data and exclude duplicates. For continuous
data (e.g. age), histograms were plotted to show distribution.
Mean (standard deviation (SD))/median (Inter-quartile range
(IQR)) were reported depending on the nature of the distribution of data (i.e. whether or not the data is normally distributed). Histogram plots and Shapiro-Wilk’s test of normality
were performed to check for normality of data, followed by
transformation where appropriate. Categorical data such as
sex, education, HIV status were illustrated using bar charts,
with associated frequencies and proportions presented in tables.
Student’s t-test was used to compare means of titers of infection in those with severe features of epilepsy and those without, if the raw or transformed data was normally distributed.
For non-parametric continuous data, Mann-Whitney U
test was used. The association between parasitic infections
(predictors) and features of epilepsy (outcomes) was determined
using a mixed effects modified Poisson regression model with
robust standard errors. Since our outcomes are binary, using
robust standard errors rectified overdispesion and produced
reliable estimates. Modified Poisson regression model was
chosen over log-binomial model for two reasons: (i) it is
not largely affected by convergence problems, and (ii) it allows
for addition of random effect(s) variable while log-Binomial

model does not. The model uses a log function to link a binary
outcome (feature of epilepsy) to a set of predictors (infections and confounders), while accounting for clustering effect
of site. To obtain crude relative risks, simple modified
Poisson regression model with site as a random effect was
used. Adjusted relative risks were obtained using multiple
modified Poisson regression models with site as a random
effect. We chose relative risk over odds ratio (OR) since the
prevalence of some features was >10%, to avoid exaggerating risks with OR. In this model, the outcomes were the
various clinical, or neurophysiological features of epilepsy (focal
seizures, status epilepticus, frequent seizures [daily/weekly],
neurological deficits, abnormal EEG, cognitive difficulties,
malnutrition) and predictors were the parasitic infections
most commonly associated with epilepsy (Toxacara canis,
Onchocerca volvulus, Plasmodium falciparum, Toxoplasma
gondii, Taenia solium, and HIV (included because increases
risk for these parasites)) combined or considered individually
together. The model was accounted for age, sex, other socioeconomic confounders and ASM use. Biological (additive)
interaction was assessed to determine public health implications of co-infections on features of epilepsy. Biologic interaction is more informative than the multiplicative interaction
in the sense that the former gives the additive effect (synergism/antagonism) of exposures on the feature of epilepsy,
by determining the relative excess risk due to interaction
(RERI). RERI enabled us to know whether the combined effect
of the exposures exceeds (synergism) or is less than (antagonism) the effect of each considered individually. RERI was
determined as follows:
Additive interaction (RERI) = (p11–p00)–[(p10–p00)+(p01–p00)]

(1)

Where;
p00- Prevalence of the epileptic feature when both infections
are absent; p11- Prevalence of epileptic feature when both infections are present; p10 and p01- Prevalence of epilepsy feature
when one infection is present.

Results
General description

A total of 997 participants with active convulsive epilepsy
from the five African sites were included in the analysis. The
overall proportion of males was 51% across all the samples,
ranging from 48% in Ifakara to 56% in Agincourt. The overall median (IQR) age was 20.0 years (13.0 – 32.5), being
lowest in Iganga (12.0, IQR: 5.0–21.0) and highest in Agincourt (29.0, IQR:18.0-45.0). There was a significant difference
in age (P=0.0001) across the sites (supplementary figure 1).
The distribution of these and other sociodemographic characteristics including education and employment status are
shown in Table 1 and most characteristics varied by site.

Antibody titres and features of epilepsy
There was significantly higher median antibody titer levels
of HIV in severe epilepsy (optical density (OD)=0.14 (IQR:
0.10-0.15)) compared to non-severe epilepsy (0.13 (IQR:
0.11-0.18)) (P<0.001). There were lower median antibody
titer levels of Onchocerca volvulus in severe epilepsy
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Table 1. Socio-demographic characteristics and comorbidities of study population by site.
Agincourt

Ifakara

Iganga

Kilifi

Kintampo

Total

n = 176

n = 287

n = 84

n = 276

n = 174

n = 997

Median age in years (IQR)

29.0
(18.0–45.0)

18.3
(12.0–30.9)

12.0
(5.0–21.0)

18.0
(11.0–27.5)

21.0
(15.0–29.0)

20.0
(13.0–32.5)

Median age (years) at onset of
seizures (IQR)

13.7
(2.6–31.1)

8.9
(2.0–16.5)

2.1
(0.5–7.9)

3.3
(1.0–13.4)

9.8
(3.0–16.8)

6.7
(1.6–16.8)

Socio-demographics

Sex; n (%)
Female

78(44.3)

150(52.3)

40(47.6)

143(51.8)

78(44.8)

489(49.0)

Male

98(55.7)

137(47.7)

44(52.4)

133(48.2)

96(55.2)

508(51.0)

Schooled

121(71.6)

160(58.6)

43(63.2)

153(60.5)

107(62.6)

584(62.6)

Unschooled

48(28.4)

113(41.4)

25(36.8)

100(39.5)

64(37.4)

350(37.5)

Employed

7(5.3)

106(72.6)

4(16.7)

42(30.9)

54(47.8)

213(38.6)

Unemployed

126(94.7)

40(27.4)

20(83.3)

94(69.1)

59(52.2)

339(61.4)

Neurologic deficits; n (%)
                                              No

139(79.9)

263(92.3)

71(84.5)

231(83.7)

143(88.3)

847(86.3)

Yes

35(20.1)

22(7.7)

13(15.5)

45(16.3)

19(11.7)

134(13.7)

No

None

185(86.1)

67(87.0)

212(82.5)

141(83.9)

605(84.4)

Yes

None

30(13.9)

10(13)

45(17.5)

27(16.1)

112(15.6)

No

157(89.2)

252(87.8)

64(77.1)

232(84.1)

150(86.2)

855(85.8)

Yes

19(10.8)

35(12.2)

19(22.9)

44(15.9)

24(13.8)

141(14.2)

Education (age≥5); n (%)

Employment (age≥18); n (%)

Co-morbidities

Cognitive impairment; n (%)

Malnutrition; n (%)

IQR=interquartile range

[optical density, OD=0.09 (IQR: 0.08-0.28)] compared to
non-severe epilepsy [0.10 (IQR: 0.08-0.36)]; P=0.038. No
significant differences for antibody tires to other infections
were noted between severe and non-severe epilepsy (Table 2).
More than three quarters (88%) of the study population
were exposed to some infection.

Associations of parasitic and HIV infections with
features of epilepsy among all participants
In the crude analysis, presence of infections as shown
in Figure 1, was associated with convulsive status epilepticus
(RR=2.79, 95% confidence interval (95%CI):2.53-3.08) and
neurologic deficits (RR=1.73, 95%CI:1.35-2.22). After adjusting
for age, sex, education and employment, presence of infections was associated with higher frequency (daily/weekly)

of seizures (RR=2.85, 95%CI:1.95-4.16), and adjusting for
these variables appeared to reduce risk for intellectual disability (RR=0.25, 95%CI:0.11-0.57) (Figure 1). More detailed
results also shown in Table 2.
In the sensitivity analysis of individual infections, exposure
to falciparum malaria increased the risk of status epilepticus
(RR=1.79, 95%CI:1.19-2.69), but reduced risk for several other
features (Table 3). HIV increased risk for seizure frequency
(RR=1.16, 95%CI:1.07-1.27) and abnormal EEG (RR=1.30,
95%CI:1.01-1.69) among others. O. volvulus increased risk
for convulsive status epilepticus (RR=2.32, 95%CI:1.35-3.98),
T. solium for abnormal EEG (RR=1.54, 95%CI:1.31-1.82) and
T. canis for neurological deficits (RR=1.69, 95%CI:1.53-1.85).
Other associations are in Table 3.
Page 6 of 18

Wellcome Open Research 2021, 6:200 Last updated: 03 SEP 2021

Table 2. Association between infection status and clinical and comorbidity features of epilepsy (pooled data).
Infection status
Feature

Crude
Relative
Risk (C.I)

P-value

Adjusted
Relative
Risk (C.I)

P-value

Uninfected
n (%)

Infected
n (%)

Focal seizures
                                                                   No
                                                                  Yes

64(11.7)
52(11.6)

482(88.3)
398(88.4)

1.08
(0.95–1.22)

0.247

0.97
(0.73–1.30)

0.873

Abnormal EEG
                                                                   No
                                                                  Yes

41(12.5)
49(12.5)

286(87.5)
342(87.5)

1.00
(0.90–1.11)

0.996

0.96
(0.83–1.11)

0.588

Status epilepticus
                                                                   No
                                                                  Yes

111(13.2)
5(3.3)

733(86.8)
148(96.7)

2.79
(2.53–3.08)

<0.001

0.90
(0.32–2.54)

0.845

Frequency of seizures
                                                          Monthly
                                                   Daily/weekly

46(10.2)
15(7.3)

405(89.8)
190(92.7)

1.14
(0.56–2.31)

0.722

2.85
(1.95–4.16)

<0.001

31(5.1)
4(3.6)

574(94.9)
108(96.4)

1.39
(0.99–1.94)

0.059

0.25
(0.11–0.57)

0.001

Neurologic deficits
                                                                   No
                                                                  Yes

102(12.0)
13(9.7)

745(88.0)
121(90.3)

1.73
(1.35–2.22)

<0.001

1.40
(0.52–3.80)

0.509

Malnutrition
                                         Not malnourished
                                                Malnourished

95(11.1)
21(14.9)

760(88.9)
120(85.1)

0.71
(0.39–1.28)

0.258

0.91
(0.48–1.73)

0.772

Cognitive/learning difficulties
No
                                                                  Yes

C.I=confidence intervals; EEG=electroencephalograph

Associations of parasitic/HIV infections with features of
epilepsy among children
In the crude analysis, exposure to parasitic/HIV infections was
associated with convulsive status epilepticus (RR=4.50,
95%CI:3.89-5.19), intellectual disability (RR=2.10, 95%CI:1.413.12), neurologic deficits (RR=1.49, 95%CI:1.10-2.05) and
with reduced risk for malnutrition (RR=0.69, 95%CI:0.59-0.80)
(Figure 2). When we adjusted for age and sex (majority had
not reached the appropriate age for employment and school
enrollment), presence of infections was associated with
convulsive status epilepticus (RR=4.68, 95%CI:3.79-5.78), intellectual disability (RR=2.13, 95%CI:1.35-3.34) and neurologic
deficits (RR=1.92, 95%CI:1.42-2.61). More detailed results
are shown in Table 4.
In the sensitivity analysis for individual infections, exposure
to P. falciparum was significantly associated with having
convulsive status epilepticus (RR=2.26, 95%CI:1.85-2.76), malnutrition (RR=1.59, 95%CI:1.20-2.11), intellectual disabilities
(RR=0.15, 95%CI: 0.13-0.17) and neurologic deficits (RR=0.47,
95%CI:0.33-0.68), after adjusting for age, sex and other
infections (Table 5). Exposure to T. canis was significantly

associated with status epilepticus (RR=1.72, 95%CI:1.33-2.21)
and neurologic deficits (RR=2.11, 95%CI:1.54-2.89) after
adjusting for age, sex and other infections. Sero-positivity to
T. gondii was protective for neurological deficits (RR=0.57,
95%CI:0.43-0.75) having controlled for age, sex and other
infections (Table 5).

Associations of infections with features of epilepsy
among adults
Only neurological deficits (RR=1.76, 95%CI:1.17-2.65) was
associated with presence of any infections in bivariate analysis.
After adjusting for age, sex, education and employment, frequent seizures (RR=2.58, 95%CI:1.71-3.89) and cognitive
difficulties (RR=0.23, 95%CI:0.11-0.47) were significantly associated with presence of infections (Figure 3). More detailed
results are shown in Table 6.
In the sensitivity analysis for individual infections, exposure
to P. falciparum infection was significantly associated with
convulsive status epilepticus (RR=1.74, 95%CI: 1.05-2.90)
and frequent seizures (RR=3.07, 95%CI: 2.14-4.42), adjusting
for age, sex, education and employment status. Additionally,
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Figure 1. Associations between infections and epilepsy features in the study population (pooled). Note: For avoidance of doubt, the
features displayed in the plot are outcomes (dependent variables). The main predictor is parasitic/HIV infections (having any of these), adjusted
for socio-demographics. Therefore, the effect size (relative risk (RR)) represents the effect of infections on a given feature, and not the other way
round. EEG=electroencephalograph; CI=confidence interval.

after controlling for the confounders, infection with O. volvulus
was significantly associated with status epilepticus (RR=2.31,
95%CI:1.36-3.93) and focal seizures (RR=0.80, 95%CI:
0.71-0.91). Further, infection with T. solium was significantly
associated with malnutrition (RR=1.53, 95%CI:1.11-2.10) in
the adjusted analysis (Table 7).

Interaction between infections and features of epilepsy
In the analysis for multiplicative interactions, several paired
infections showed interactions (Table 8 and supplementary
table 1). In particular, P. falciparum and HIV interacted to
increase the risk for convulsive status epilepticus (RR=2.35,
95%CI:1.38-4.00) and frequent seizures (RR=4.14, 95%CI:3.045.65), but the interaction reduced the risk for cognitive
impairment (RR=0.32, 95%CI: 0.24-0.44). Similarly, HIV
interacted with O. volvulus to increase the risk for convulsive

status epilepticus (RR=4.46, 95%CI:2.05-9.71), but reduced
the risk for frequent seizures (RR=0.74, 95%CI:0.63-0.88).
In the analysis for biological interactions, T. gondii and
T. canis interacted synergistically to increase the risk of convulsive status epilepticus (RERI = 0.92, 95%CI:0.46-1.38) while
P. falciparum interacted with HIV to reduce the risk of convulsive status epilepticus (RERI = -4.02, 95%CI:-7.95 - -0.08)
(Table 9). Detailed results for biological interactions are shown
in supplementary table 2, while those for population attributable
fractions are in supplementary table 3.

Discussion

This study provides important evidence that parasitic infections that infect the CNS are not only associated with epilepsy,
but also determine the occurrence of features and phenotypes
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<0.001
0.005
0.459
<0.001
0.001
0.041
0.006

0.33
0.28–0.37

1.79
1.19–2.69

0.85
0.55–1.31

0.23
0.21–0.26

0.61
0.46–0.82

0.83
0.69–0.99

0.79
0.66–0.93

Focal seizure

Status epilepticus

Frequent seizures

Cognitive difficulties

Neurologic deficits

Abnormal EEG

Malnutrition

1.33
0.39–4.56

1.30
1.01–1.69

0.59
0.28–1.26

0.652

0.041

0.174

0.001

0.001

1.16
1.07–1.27
0.71
0.58–0.88

0.005

0.017

P–value

1.88
1.21–2.93

1.14
1.02–1.26

RR
(C.I)

(ref: -ve)

HIV (+ve vs –ve)

0.84
0.62–1.14

1.19
0.94–1.51

0.79
0.47–1.33

1.01
0.74–1.36

1.01
0.75–1.37

0.71
0.64–0.80

1.05
0.81–1.37

RR
(C.I)

0.258

0.150

0.379

0.967

0.950

<0.001

0.691

P–value

(ref: -ve)

T. Gondii (+ve vs
–ve)

0.94
0.73–1.21

0.93
0.69–1.26

0.79
0.32–1.98

1.06
0.82–1.38

0.76
0.68–0.84

2.32
1.35–3.98

0.81
0.71–0.93

RR
(C.I)

0.654

0.639

0.613

0.640

<0.001

0.002

0.003

P–value

(ref: -ve)

O. Volvulus (+ve vs
–ve)

Note: Frequent seizures – having seizures on a daily/weekly basis. EEG=electroencephalograph; RR=risk ratio; C.I=confidence intervals

P–value

(ref: -ve)

P. falciparum (+ve
vs –ve)

RR
(C.I)

Epilepsy
features (outcomes)

Infections
(predictors)

Table 3. Adjusted associations of features of epilepsy and individual infections (pooled data).

1.97
1.18–3.27

1.54
1.31–1.82

0.76
0.26–2.24

0.55
0.15–2.04

0.47
0.10–2.28

0.83
0.24–2.80

0.57
0.07–4.72

RR
(C.I)

0.009

<0.001

0.619

0.374

0.0.347

0.759

0.606

P–value

(ref: -ve)

T. solium (+ve vs
–ve)

1.12
0.86–1.47

0.96
0.84–1.09

1.69
1.53–1.85

1.16
0.67–2.00

1.27
1.02–1.56

1.28
0.29–5.56

0.81
0.56–1.17

RR
(C.I)

0.396

0.517

<0.001

0.603

0.030

0.743

0.263

P–value

(ref: -ve)

T. canis (+ve vs –ve)
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Figure 2. Associations between infections and epilepsy features in children (<18 years). Note: For avoidance of doubt, the features
displayed in the plot are outcomes (dependent variables). The main predictor is parasitic/HIV infections (having any of these), adjusted for sociodemographics. Therefore, the effect size (relative risk (RR)) represents the effect of infections on a given feature, and not the other way round.
EEG=electroencephalograph; CI=confidence interval.

of epilepsy. In children with epilepsy, exposure to infections
is particularly associated with convulsive status epilepticus,
neurological deficits and intellectual disability, while in adults
it is associated with frequent seizures. Individual infections
may increase some features (e.g. falciparum malaria increasing
risk for convulsive status epilepticus) but not others. These
infections may interact synergistically or antagonistically to
affect the features of epilepsy, and their prevention may reduce up
to 26% severe epilepsy.

and reliable associations should be measured from cut-offs
derived from high antibody titres. Using predefined cut-offs,
infections were more prevalent across all features considered,
indicating that these infections could be potential risk
factors for development of these epilepsy features. The
prevalence of infections were significantly greater than in
the general population since they are based on an epilepsy
cohort, whose exposure to infections is already known to be
relatively greater (Carter et al., 2004).

Antibody titres and prevalence for parasitic/HIV
infections
There was significant difference in median antibody titer levels between severe and non-severe epilepsy only for HIV
(P<0.001) and Onchocerca volvulus (P=0.038), suggesting that these levels are ubiquitous representation of exposure,

Associations between any parasitic/HIV infections and
features of epilepsy in all populations
Among all the study population, exposure to any of the infections were associated with increased risk of having frequent
(daily/weekly) seizures and an increased risk of cognitive
difficulties, after controlling for confounding effects, including
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Table 4. Association between infection status and clinical and comorbid features of epilepsy in children (<
18years).
Infection status
Feature

Crude
Relative Risk
(C.I)

P-value

Adjusted
Relative Risk
(C.I)

P-value

Uninfected
n (%)

Infected
n (%)

                  No
                  Yes

34(14.2)
26(14.2)

205(85.8)
157(85.8)

1.19
(0.94-1.51)

0.155

               No
        Yes

19(16.7)
23(13.5)

95(83.3)
148(86.5)

1.11
(0.88-1.40)

0.366

            No
       Yes

56(16.8)
4(4.6)

278(83.2)
84(95.4)

4.50
(3.89-5.19)

<0.001

4.68
(3.79-5.78)

<0.001

15(9.3)
10(9.7)

146(90.7)
93(90.3)

1.05
(0.75-1.47)

0.783

1.09
(0.67-1.77)

0.740

27(9.6)
2(4.4)

254(90.4)
43(95.6)

2.10
(1.41-3.12)

<0.001

2.13
(1.35-3.34)

0.001

Neurologic deficits
                        
              No
                              
        Yes

54(14.6)
5(10.2)

316(85.4)
44(89.8)

1.49
(1.10-2.05)

0.011

1.92
(1.42-2.61)

<0.001

Malnutrition
                          Not malnourished
                                 Malnourished

47(13.0)
13(21.3)

314(87.0)
48(78.7)

0.69
(0.59-0.80)

<0.001

0.93
(0.80-1.09)

0.392

Focal seizures
                    
                    
Abnormal EEG
                       
                              

Status epilepticus
                          
                               

Frequency of seizures
                                       Monthly
                                    Daily/weekly
Cognitive/learning difficulties
                      
                No
                     
                 Yes

1.14
(0.88-1.48)
1.19
(1.05-1.35)

0.324

0.008

EEG=electroencephalograph; C.I=confidence intervals

the use of ASM. HIV-positive individuals have increased
risk of abnormal EEG, which has been noted in previous
studies (Kellinghaus et al., 2008). T. canis was associated with
neurological deficits which is not surprising since neurological involvement has been reported (Finsterer & Auer, 2007).
Associations that appeared protective were observed especially for some specific infections. This may be due to absence
of these features and phenotypes when samples for positive
assays were collected or may be a spurious association. Since
susceptibility to infections and pathogenesis of epilepsy following these infections is different between children and adults,
it warranted evaluations of these associations between two
population strata i.e. adults and children/minors separately.

Associations between any parasitic/HIV infections and
features of epilepsy in children
Among children with epilepsy, we found that exposure to
infections was associated with higher risk of having status
epilepticus, intellectual disabilities and neurologic deficits after

adjusting for age and sex. Analysis of individual infections
showed that P. falciparum increased the risk for convulsive
status epilepticus, and T. canis that for neurological deficits,
while interaction of several infections may explain the intellectual
disability.
Children have low immunity to infections and also have a
developing brain, and it is not surprising that infections determine three features of epilepsy that are pathognomonic of
severe childhood seizure disorders. Convulsive status epilepticus is common in children and previous studies showed that
malaria is the most important cause (Sadarangani et al., 2008).
Kariuki et al. in 2011 hypothesized that the non-malarial
status epilepticus that did not decline over a period of malaria
reduction was probably caused by epilepsy (Kariuki et al.,
2011). It has been established in a recent multisite study
that status epilepticus occurs in over 25% of people with
epilepsy (Kariuki et al., 2015a), and infections may contribute
to this excess burden of prolonged seizures.
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2.26
1.85-2.76

0.80
0.42-1.53

0.15
0.13-0.17

0.47
0.33-0.68

0.61
0.46-0.81

1.43
1.01-2.04

Status epilepticus

Frequent seizures

Cognitive difficulties

Neurologic deficits

Abnormal EEG

Malnutrition

0.046

0.001

<0.001

<0.001

0.506

<0.001

0.510

P-value

1.99
0.86-4.58

1.14
1.02-1.28

0.41
0.07-2.31

0.32
0.10-1.08

1.48
1.07-2.06

0.44
0.03-5.96

0.64
0.19-2.13

RR
(C.I)

0.106

0.019

0.314

0.066

0.019

0.539

0.467

P-value

HIV (+ve vs –ve)
(ref: -ve)

0.97
0.27-3.49

1.15
0.84-1.57

0.57
0.43-0.75

0.89
0.72-1.10

1.02
0.69-1.50

0.51
0.14-1.80

0.75
0.68-0.82

RR
(C.I)

0.966

0.377

<0.001

0.275

0.933

0.327

<0.001

P-value

T. Gondii (+ve vs –ve)
(ref: -ve)

0.78
0.45-1.34

1.07
0.59-1.95

0.84
0.56-1.26

1.54
0.55-4.29

0.91
0.52-1.58

0.37
0.18-0.75

0.90
0.37-2.24

RR
(C.I)

0.368

0.826

0.387

0.409

0.742

0.006

0.837

P-value

O. Volvulus (+ve vs –ve)
(ref: -ve)

5.20
0.98-27.7

1.79
1.63-1.98

2.81
1.94-4.09

1.72
1.48-2.01

0.053

<0.001

<0.001

<0.001

1.35
1.20-1.52

0.78
0.58-1.05

2.11
1.54-2.89

1.28
0.68-2.40

1.41
1.03-1.94

No convergence

0.99
0.49-2.00

RR
(C.I)

1.72
1.33-2.21

0.822

P-value

<0.001

0.097

<0.001

0.444

0.033

<0.001

0.986

P-value

T. canis (+ve vs –ve)
(ref: -ve)

No convergence

0.82
0.14-4.69

RR
(C.I)

T. solium (+ve vs –ve)
(ref: -ve)

Note: No convergence – the model would not produce parameter estimates due to inadequate cell frequencies; Frequent seizures – having seizures on a daily/weekly basis. EEG=electroencephalograph;
RR=relative risk; C.I=confidence intervals

0.90
0.68-1.21

RR
(C.I)

P. falciparum (+ve
vs –ve)
(ref: -ve)

Focal seizure

Epilepsy
features (outcomes)

Infections
(predictors)

Table 5. Adjusted associations of infections and features of epilepsy among minors (<18 years).
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Figure 3. Association between infections and features of epilepsy in adults (≥18 years). Notes: For avoidance of doubt, the features
displayed in the plot are outcomes (dependent variables). The main predictor is Central Nervous System infections (having any of these), adjusted
for socio-demographics. Therefore, the effect size (relative risk (RR)) represents the effect of infections on a given feature, and not the other way
round. EEG=electroencephalograph; CI=confidence interval.

Associations between any parasitic/HIV infections and
features of epilepsy in adults
Among adults with epilepsy, exposure to any infection was associated with increased risk for frequent seizures, but reduced
risk for intellectual disability. Analysis of individual impairments shows that the increased risk for frequent seizures,
status epilepticus was determined by falciparum malaria,
which appeared to reduce the risk for intellectual disability in
adults, perhaps suggesting these are related to other causes.
Status epilepticus was also increased following O. volvulus,
with other infections showing protection against some of these
features.
The positive association of infections with frequent seizures is expected, since we have demonstrated in children that
repetitive seizures are highly attributable to malaria (Kariuki
et al., 2011). Presence of any infections were protective for
intellectual disability in adults with epilepsy perhaps because
of absence or low frequency of infections in this group of
people movement of adults with cognitive difficulties is

restricted indoors, resulting in less exposure to infections.
Alternatively, it may be due to reporting bias whereby adults
with epilepsy conceal their cognitive impairments, which is
easily recognized as a condition for children (Carter et al.,
2005) or due to counselling out of effect sizes of infections
that confers susceptibility by those that reduces risk.

Association of individual parasitic/HIV infections with
features of epilepsy
When we probed the effects of individual infections on the features of epilepsy, P. falciparum was protective for most epilepsy
features, except for status epilepticus. The same case applied
to children, but in adults, P. falciparum infection was associated with increased risk of both status epilepticus and
daily/weekly seizures. This finding agrees with that of another
study done in Africa, where infection with falciparum malaria
were important risk factors for status epilepticus (Kariuki
et al., 2015a). We also found that exposure to falciparum
malaria may in part determine the risk for malnutrition in those
with epilepsy, supporting the previous association between
Page 13 of 18
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Table 6. Association between infection status and clinical and comorbid features of epilepsy in adults (≥18
years).
Infection status
Feature

Crude
Relative Risk
(C.I)

P-value

Adjusted
Relative Risk
(C.I)

P-value

Uninfected
n (%)

Infected
n (%)

30(9.8)
26(9.7)

277(90.2)
241(90.3)

0.94
(0.81-1.09)

0.399

0.99
(0.81-1.21)

0.911

Focal seizures
                           
                                

           No
      Yes

Abnormal EEG
                               
                               

       No
       Yes

22(10.3)
26(11.8)

191(89.7)
194(88.2)

0.93
(0.81-1.07)

0.301

0.97
(0.83-1.14)

0.739

           No
    Yes

55(10.8)
1(1.5)

455(89.2)
64(98.5)

1.19
(0.62-2.26)

0.600

0.89
(0.33-2.40)

0.814

Frequency of seizures
                                       Monthly
                                    Daily/weekly

31(10.7)
5 (4.9)

259(89.3)
97(95.1)

1.77
(0.85-3.71)

0.127

2.58
(1.71-3.89)

<0.001

Cognitive/learning difficulties
                               
       No
                         
             Yes

4 (1.2)
2 (3.0)

320(98.8)
65(97.1)

0.51
(0.13-1.93)

0.322

0.23
(0.11-0.47)

<0.001

Neurologic deficits
                                
                                  

48 (10.1)
8 (9.4)

429(89.9)
77(90.6)

1.76
(1.17-2.65)

0.006

1.46
(0.59-3.65)

0.414

48 (9.7)
8 (10)

446(90.3)
72(90)

0.83
(0.51-1.34)

0.437

0.89
(0.48-1.66)

0.716

Status epilepticus
                            
                                  

      No
    Yes

Malnutrition
                        Not malnourished
                                  Malnourished

EEG=electroencephalograph; C.I=confidence intervals

malaria and malnutrition in general hospital admissions
(Gone et al., 2017), but other factors involved in this association should be considered. HIV was a risk factor for frequent daily/weekly seizures, and abnormal EEG, suggesting it
has neurological involvement. Seizures have been reported in
HIV with or without epilepsy (Kellinghaus et al., 2008);
frequent seizures in our study are likely due to epileptogenic
nature of HIV since its negative association with neurological
deficits appears to rule out contribution by brain damage.
O. volvulus was protective for focal seizures and frequent
seizures but increased the risk for status epilepticus. O. volvulus likely has diffuse brain involvement resulting in convulsive status epilepticus with a generalized onset in the brain,
thus the negative association with focal seizures. Taenia solium
increased the risk of having abnormal EEG but reduced the
risk of early onset seizures. The finding that T. solium appeared
to reduce the risk of early onset seizures may be because it is
more common in adult onset epilepsy (Ngugi et al., 2013).

Interaction of parasitic/HIV infections and features of
epilepsy
More interactions were noted in the additive scale than in the
multiplicative scale, but the later would only be helpful in
examining the contribution of a risk factor to a disease. Interaction on the additive scale has public health importance in
that it is easier to quantify the frequency of a disease that
would be controlled by the removal of risk factors. The many

significant combinations of interaction in the multiplicative
scale suggests that multiple infections determine the features
and phenotypes of epilepsy in Africa. Interaction tests
performed on additive scale revealed that infections interact either synergistically or antagonistically in influencing
the features of epilepsy. For instance, Toxoplasma gondii and
Toxocara canis interacted synergistically to increase the risk
of status epilepticus, implying that the number of status epilepticus cases due to the coinfection is higher than the total
number of cases contributed by the two infections separately.
In contrast, P. falciparum and HIV interacted antagonistically towards status epilepticus, implying that co-infections
worsen the prognosis of epilepsy, and can also be found in
those with milder features. These interaction findings support the need to screen for multiple infections in people with
epilepsy.

Strengths and limitations
Strengths: This study had more than the minimum required
sample size, meaning the study had enough power to answer
our research questions. Also, being a multisite design, the findings can be generalized across ecological zones considered.
Additionally, the mixed effects model used in this study took
accounted for the correlations (homogeneity) within sites and
heterogeneity across sites. Limitations: We only studied active
convulsive epilepsy. The infections were assayed for exposure and not really a measure of impact of severe disease
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0.125
0.033
<0.001
0.001
0.685
0.772
<0.001

1.13
0.96–1.34

1.74
1.05–2.90

3.07
2.14–4.42

0.42
0.26–0.70

1.15
0.59–2.24

0.97
0.78–1.21

0.68
0.56–0.82

Focal seizures

Status epilepticus

Frequent seizures

Cognitive difficulties

Neurologic deficits

Abnormal EEG

Malnutrition

1.07
0.43–2.66
0.883

0.102

0.001

0.68
0.55–0.86
1.46
0.93–2.30

0.050

0.110

0.81
0.66–1.00

0.84
0.68–1.04

0.05

0.015

1.12
1.02–1.23
1.88
1.22–2.91

P–value

RR
(C.I)

(ref: -ve)

HIV (+ve vs –ve)

1.09
0.63–1.89

1.17
0.80–1.70

0.84
0.40–1.76

1.02
0.69–1.51

1.02
0.77–1.35

0.71
0.64–0.80

1.05
0.81–1.35

RR
(C.I)

0.763

0.418

0.644

0.927

0.893

<0.001

0.719

P–value

(ref: -ve)

T. Gondii (+ve vs –ve)

0.835

0.0.005

0.83
0.73–0.95
0.96
0.66–1.41

0.603

0.750

0.055

0.002

0.001

P–value

0.77
0.29–2.04

0.96
0.73–1.25

0.63
0.39–1.01

2.31
1.36–3.93

0.80
0.71–0.91

RR
(C.I)

(ref: -ve)

O. Volvulus (+ve vs –ve)

1.53
1.11–2.10

0.90
0.52–1.56

No
convergence

No
convergence

1.38
0.15–12.6

0.83
0.25–2.81

0.57
0.07–4.71

RR
(C.I)

0.009

0.719

0.778

0.768

0.600

P–value

(ref: -ve)

T. solium (+ve vs –ve)

1.19
0.86–1.64

1.25
1.02–1.54

1.18
0.77–1.81

1.19
0.77–1.83

0.90
0.64–1.28

1.28
0.28–5.89

0.81
0.57–1.17

RR
(C.I)

0.300

0.035

0.441

0.443

0.566

0.749

0.269

P–value

(ref: -ve)

T. canis (+ve vs –ve)

Note: No convergence – the model would not produce parameter estimates due to inadequate cell frequencies; Frequent seizures – having seizures on a daily/weekly basis. EEG=electroencephalograph;
RR=relative risk; C.I=confidence intervals

P–value

(ref: -ve)

P. falciparum (+ve
vs –ve)

RR
(C.I)

Epilepsy
features (outcomes)

Infections
(predictors)

Table 7. Adjusted associations of infections and features of epilepsy among adults (≥18 years).
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Table 8. Statistical (multiplicative) interactions of infections and epilepsy features.
P. falciparum

HIV

T. gondii

O. volvulus

T. solium

T. canis

P. falciparum
HIV

Status epilepticus+
Frequent seizures+
Cognitive difficultiesNeurological deficits-

T. gondii

Focal seizuresStatus epilepticus+
Frequent seizures+
Cognitive difficulties-

Abnormal EEG+

O. volvulus

Focal seizuresCognitive difficultiesAbnormal EEG-

Focal seizures-

NONE
+

Status epilepticus

Frequent seizures-

Neurologic deficitsT. solium

NONE

NONE

NONE

Abnormal EEG+

T. canis

Focal seizureFrequent seizures+
Cognitive difficulties-

Abnormal EEG+

NONE

NONE
Focal seizuresFrequent seizures-

Neurological deficits+
No ASM use+
Notes: +Interaction increases risk; Interaction reduces risk; ASM=anti-seizure medication
Table 9. Additive (biological) interactions of parasitic/HIV infections in the risk for epilepsy features.
P. falciparum

HIV

T. gondii

O. volvulus

T. solium

T. canis

P. falcip
HIV

Status epilepticus-

T. gondii

NONE

NONE

O. volvulus

NONE

+
Abnormal EEG- Status epilepticus

T. solium

NONE

NONE

T. canis

No ASM use-

NONE

Cognitive difficultiesNONE

NONE
NONE

NONE

Notes: + synergism; - antagonism; ASM=anti-seizure medication

on epilepsy, which would be done with longitudinal cohort
studies. Another cause of concern was the possibility of recall
bias since participants were interviewed for some epilepsy
features and the inherent challenge of inferring direction of
causality for cross-sectional studies. Unmeasured risk factors
could contribute to the association between infections and
epilepsy features i.e. residual confounding.

cognition being important in children and frequent seizures
in adults. Taken together these findings suggests that not only
are infections associated with epilepsy, they also determine
the presentation of epilepsy in terms of features and phenotypes. Control of infections may reduce the risk of epilepsy
becoming severe in addition to preventing epilepsy directly
caused by infections in the community.

Conclusions

Previous publications

Features and phenotypes of epilepsy in Africa may be determined by infections and the direction of association depends on
the type, frequency of infection and their interaction. Exposure
to parasitic infections determine different types of features and
phenotypes for children and adults, with status epilepticus and

Part of this data was published in PLoS Negl Trop Dis
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038481/)
and in Lancet Neurol (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581814/) as case-control studies to examine exposure to infections as risk factors for developing epilepsy.
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However, none of these two articles explored the role of exposure to infections in the occurrence of features, outcomes and
phenotypes among people with epilepsy, which is now presented in this paper. More details on justification for the current
analysis is provided in the introduction section of the paper.

Data availability
Underlying data

Harvard Dataverse: Infections and Epilepsy.
org/10.7910/DVN/WQZBUX (Langat et al., 2021).

https://doi.

This project contains the following underling data:
(i) epilepsydata_deidentified_ID.tab (used for calculating
the association of exposure to infections with epilepsy
features and phenotypes)
For ethical considerations and to comply with the language
in the informed consent forms, the access to the dataset is
controlled for general research use. Please request to access the
data by completing the forms in the provided link to the data,
following which permissions will be granted using procedures
governed by the Data Governance Committee (DGC) of the
Centre for Geographic Medicine Research Coast, Kenya
Medical Research Institute. Data will be made available with
the approval of the KEMRI Wellcome Trust Research Programme Data Governance Committee, only where anonymization
can be adequately achieved to protect the privacy and confidentiality of the participants/respondents and any mentioned individuals and institutions, and where the proposed
use is seen as relevant to the nature of the data. Where
the DGC recommend this, the national KEMRI Science and
Ethics Review Unit may also be asked to approve the proposed use. Conditions for data sharing are outlined in a
KWTRP Data Sharing Agreement, including that the requestor shall use the data only for the agreed purpose as stipulated
in the application form; shall agree to keep the data strictly

confidential and shall not in any way attempt to seek to discover the identity of data subjects, to compromise or infringe
on their privacy and confidentiality of their information.

Extended data
Harvard Dataverse: Infections and Epilepsy.
org/10.7910/DVN/WQZBUX (Langat et al., 2021).

https://doi.

This project contains the following extended data:
(i)
Infections and Epilepsy_Codebook.xlsx (description
of variables codes and labels)
(ii)

Infections Epilepsy Data Readme File.txt (brief
description of the study aim and processes)

(iii)

Infections and Epilepsy.do (SATA v15 analysis script)

(iv)

StageIII SEEDS-Clinical Examination.doc (clinical
examination form)

(v)

StageIII SEEDS-Clinical History (Twi).doc (clinical
history form)

(vi)

StageIII SEEDS-EEEG.doc (EEG interpretation form)

(vii) S
 tageIII
SEEDS-Socio-Demography
Above
18(Twi).doc (adults’ sociodemographic and medical
history form)
(viii) S
 tageIII
SEEDS-Socio-Demography
Under
18(Twi).doc (children’s sociodemographic and medical
history form)
(ix)

Supplementary
materials_19July2021.docx
(supplementary appendix, figure and tables).

Data are available under the terms of the Creative Commons
Attribution 4.0 International license (CC-BY 4.0).
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